Danaher Easily Beats Q2 Street View With Growth From Base Business; FY22 Outlook Unchanged

  • Danaher Corp DHR has logged Q2 FY22 adjusted EPS of $2.76, up 12% Y/Y, surpassing the estimate of $2.35.
  • Sales increased 7.5% to $7.75 billion, with 9.5% non-GAAP core and 8.0% non-GAAP base business core revenue growth, beating the $7.32 billion estimate.
  • Operating cash flow reached $2 billion. Non-GAAP free cash flow reached $1.7 billion.
  • The gross margin remained unchanged at 60.9%, and the operating margin improved slightly from 27.8% a year ago to 28.4%.
  • Rainer M. Blair, President & CEO, stated, "We are pleased with our strong start to 2022. Our teams executed well in a challenging environment to deliver high-single-digit core revenue growth, double-digit adjusted earnings per share growth, and $2.0 billion of operating cash flow. We were particularly encouraged with the high-single-digit growth in our base business and believe we gained market share across the portfolio."
  • Outlook: For Q3 FY22, Danaher anticipates that non-GAAP base business core revenue growth will be in the high-single-digit percent range. 
  • For FY22, the company reaffirms the non-GAAP base business core revenue growth outlook in high-single-digit percentages.
  • Price Action: DHR shares are up 3.72% at $265.52 during the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!